Cara Therapeutics, Inc. - stock earnings
CARA Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 6, 2024 AfterMarket | - / -0.4060000000 | - | - / 1.7 million | - |
CARA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -32.3 million USD | 3.0 million USD |
| 2023Q3 | -28.0 million USD | 4.9 million USD |
| 2023Q2 | -31.5 million USD | 6.9 million USD |
| 2023Q1 | -25.7 million USD | 6.2 million USD |
| 2022Q4 | -29.4 million USD | 3.3 million USD |
| 2022Q3 | -22.5 million USD | 10.8 million USD |
| 2022Q2 | -3.9 million USD | 23.0 million USD |
| 2022Q1 | -27.6 million USD | 4.8 million USD |
| 2021Q4 | -33.4 million USD | 821000 USD |
| 2021Q3 | -1.0 million USD | 20.3 million USD |
| 2021Q2 | -30.7 million USD | ? USD |
| 2021Q1 | -23.3 million USD | 1.9 million USD |
| 2020Q4 | 78.9 million USD | 112.1 million USD |
| 2020Q3 | -16.5 million USD | 9.3 million USD |
| 2020Q2 | -25.1 million USD | 5.6 million USD |
| 2020Q1 | -28.9 million USD | 8.1 million USD |
| 2019Q4 | -28.6 million USD | 4.5 million USD |
| 2019Q3 | -32.8 million USD | 5.8 million USD |
| 2019Q2 | -23.0 million USD | 5.2 million USD |
| 2019Q1 | -22.0 million USD | 4.4 million USD |
| 2018Q4 | -20.7 million USD | 5.5 million USD |
| 2018Q3 | -19.4 million USD | 5.1 million USD |
| 2018Q2 | -17.2 million USD | 2.9 million USD |
| 2018Q1 | -16.8 million USD | ? USD |
| 2017Q4 | -14.2 million USD | 911000 USD |
| 2017Q3 | -12.4 million USD | ? USD |
| 2017Q2 | -9.3 million USD | 911000 USD |
| 2017Q1 | -22.2 million USD | 911000 USD |
| 2016Q4 | -22.0 million USD | 79000 USD |
| 2016Q3 | -11.5 million USD | 72000 USD |
| 2016Q2 | -13.1 million USD | 79000 USD |
| 2016Q1 | -10.7 million USD | 7000 USD |
| 2015Q4 | -9.5 million USD | 1.4 million USD |
| 2015Q3 | -4.8 million USD | 2.4 million USD |
| 2015Q2 | -5.7 million USD | 874000 USD |
| 2015Q1 | -4.7 million USD | 489000 USD |
| 2014Q4 | -4.2 million USD | 914000 USD |
| 2014Q3 | -6.5 million USD | 1.1 million USD |
| 2014Q2 | -3.6 million USD | 960000 USD |
| 2014Q1 | -3.4 million USD | 178000 USD |
| 2013Q4 | -2.1 million USD | 973000 USD |
| 2013Q3 | -4.6 million USD | 1.0 million USD |
| 2013Q2 | 5.3 million USD | 10.0 million USD |
| 2013Q1 | -2.6 million USD | ? USD |
| 2012Q4 | -1.8 million USD | 1.2 million USD |
CARA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -118.5 million USD | 21.0 million USD |
| 2022 | -83.4 million USD | 41.9 million USD |
| 2021 | -88.2 million USD | 23.0 million USD |
| 2020 | 8.4 million USD | 135.1 million USD |
| 2019 | -106.4 million USD | 19.9 million USD |
| 2018 | -74.0 million USD | 13.5 million USD |
| 2017 | -58.1 million USD | 911000 USD |
| 2016 | -57.3 million USD | 86000 USD |
| 2015 | -24.7 million USD | 3.8 million USD |
| 2014 | -17.7 million USD | 3.2 million USD |
| 2013 | -4.0 million USD | 12.0 million USD |
| 2012 | -6.3 million USD | 1.2 million USD |
| 2011 | -9.8 million USD | ? USD |
CARA
Price: $0.78
52 week price:
Earnings Per Share: -2.19 USD
P/E Ratio: -0.27
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 393100
Ebitda: -12.8 millionMarket Capitalization: 46.5 million